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   One hundrcd and seventy eight paticn亡s trea亡ed in ottr clinic werc a且alyzed． The five．year survlval
rates for th6 patients 〈69 cdses） given transurethral resection 〈TUR）， total cystectomy （65 cases） and
palliative treatment （40 cases） were 92．70／．， 61．10／， and 3．90／．， respectively． The four patients who
could not be treated lived no longer than one month．
   The five－year survival rate for the patients treated with TUR of the tumor was the highest． The
recurrence rate for the TUR group was 19．50／o at one year， 39．50／． at three years and 47．1％ at five
years a’fter surgery； and， it was higher in the patients with histologically high grade tumors． Generally，
we obtained good resul亡s wi亡h TUR， bu亡亡。亡al cys亡ec亡omy had亡。 be performed Iater on three paticnts
due to Progression of the tumor． We felt the need for an indicator to express the biological activity
of the tumor， and maintain that regular follow－up by endoscopy and cytology is manddeory．
   The clinical results of the total cystectomy and urinary diversion were considered to be satisfactory
compared to other reports； and， patients with high stage tumor had poor prognosis． Five patients
died of progression og the diseasie after total cystectomy． Operative mQrtality was 10．70／．， which
should be decreased by avoiding 6perativc morbidity． ln’ our experience， two－stage operations or
preoperative irradiation can increase the・indication for total cystectomy｛ and， improved clinical results
ate expected．
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Tabre 1． Sex and age distribution of
     bladder tumor patients

















Total 137 41 178
Table 2． Treat皿ent
Treatment No， Cases
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Table 4．Duration until initial recurrence
after TUR－Bt
Duration untit lnitial
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Table 5． aases of cancer death after total cystectomy
Case Age SexHistology Duration fromOp． to Death
1．M，W， 62 F TCC G3 pT3 NX l yr．
2． S，M． 57 M TCC G3 pT 3 NX 2 yrs， l mo，
3． T．T， 63 M TCC G 3 pT4 N l 2 yrs，4mos，
4． N， Y． 72 F SCCpT 3 N 1 1 yr． 3 mos．
5．A．S， M M TCC G3 pT3 Nl l yr． lmo，
TCC ： Transitional Cell Carcinome
SCC ： Squamous Cell Carcinoma
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Table 6． Early postoperative morbidity
     after total cystectomy
Early Complication
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